Section one: Contracting authority
one.1) Name and addresses
University of Exeter
Northcote House
Exeter
EX4 4QH
Contact
Sam Barker
Telephone
+44 11111
Country
United Kingdom
Region code
UKK4 - Devon
National registration number
RC000653
Internet address(es)
Main address
Buyer's address
https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/53042
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Education
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Use of PET and MRI imaging facilities, plus [11C] radiopharmaceuticals at Invicro LLC
Reference number
UOE/2022/064/SB
two.1.2) Main CPV code
- 33692000 - Medical solutions
two.1.3) Type of contract
Supplies
two.1.4) Short description
PET and MRI scanning, radioligand production, and biomarker analysis
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £1,883,380
two.2) Description
two.2.2) Additional CPV code(s)
- 33692000 - Medical solutions
two.2.3) Place of performance
NUTS codes
- UKK4 - Devon
two.2.4) Description of the procurement
PET and MRI scanning, radioligand production, and biomarker analysis
• Only UK provider of PET tracers [11C]BU90008, [11C]SA4503, and [18F]BCPP-EF, that are currently used for our studies.
• Invicro is located within the Hammersmith Hospital Campus, its location accommodates research participants for image and clinical assessments without increased burden and travel for the participants. While also reducing cost and time to conduct the studies.
• [11C] tracers (with short half-life of about 20 minutes) and of [18F] radiotracers (with half-life of about 120 minutes) are produced in house and the short half-life of the [11C] tracers means Invicro’s two in-house cyclotron’s must be used. Their radioligand development platform means implementation of new tracers is not available at other facilities.
• Invicro has the equipment and facilities to collect arterial blood samples during the scans and analyze the quantity of the radioactive metabolites on site.
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
The research conducted by the Neurodegeneration Imaging Group requires the use of [11C] radiopharmaceutical, as well as an imaging facility that can provide PET-MR scanners with accompanying arterial line capabilities. Due to the very short half-life of the the [11C] tracers, these research studies are limited to facilities that have an in-house cyclotron. Imanova, trading as Invicro, not only has the in-house production of the [11C] tracers, which have a short half-life of approximately 20 minutes and the [18F] radiotracers with a half-life of approximately 120 minutes, they also host two cyclotrons on site. This coupled with the research facility’s location in London, where participants who are participating in the study have clinics has resulted in, for technical reasons, only Invicro being able to provide the tracers and in-house service to deliver the research outputs at present.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract
Title
TBC
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
13 October 2022
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Imanova
Invicro LLC
Country
United Kingdom
NUTS code
- UKI - London
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1,883,380
Total value of the contract/lot: £1,883,380
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
Royal Court of Justice
London
Country
United Kingdom